90 related articles for article (PubMed ID: 2511724)
21. Recombinant human interleukin-3 (rH IL-3) in combination with remission induction chemotherapy in patients with relapsed acute myelogenous leukemia (AML): a phase I/II study.
Wielenga JJ; Vellenga E; Groenewegen A; Sonneveld P; Löwenberg B
Leukemia; 1996 Jan; 10(1):43-7. PubMed ID: 8558936
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
Dahl GV; Kalwinsky DK; Mirro J; Look AT; Pui CH; Murphy SB; Mason C; Ruggiero M; Schell M; Johnson FL
J Clin Oncol; 1990 Feb; 8(2):295-303. PubMed ID: 2299372
[TBL] [Abstract][Full Text] [Related]
23. Extension of remission in acute nonlymphocytic leukemia.
Dutcher JP; Wiernik PH
J Clin Oncol; 1988 Nov; 6(11):1783-4. PubMed ID: 3054006
[No Abstract] [Full Text] [Related]
24. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
25. Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia.
Powell BL; Capizzi RL; Lyerly ES; Cooper MR
J Clin Oncol; 1986 Jan; 4(1):95-7. PubMed ID: 3001234
[TBL] [Abstract][Full Text] [Related]
26. Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia.
Shi G; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1993 Oct; 70(2):140-1. PubMed ID: 8242596
[TBL] [Abstract][Full Text] [Related]
27. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
[TBL] [Abstract][Full Text] [Related]
29. A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study.
Steuber CP; Civin C; Krischer J; Culbert S; Ragab A; Ruymann FB; Ravindranath Y; Leventhal B; Wilkinson R; Vietti TJ
J Clin Oncol; 1991 Feb; 9(2):247-58. PubMed ID: 1988573
[TBL] [Abstract][Full Text] [Related]
30. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
Krug U; Röllig C; Koschmieder A; Heinecke A; Sauerland MC; Schaich M; Thiede C; Kramer M; Braess J; Spiekermann K; Haferlach T; Haferlach C; Koschmieder S; Rohde C; Serve H; Wörmann B; Hiddemann W; Ehninger G; Berdel WE; Büchner T; Müller-Tidow C; ;
Lancet; 2010 Dec; 376(9757):2000-8. PubMed ID: 21131036
[TBL] [Abstract][Full Text] [Related]
31. [Clinical studies of BH-AC-DMP in adult acute nonlymphocytic leukemia].
Kato Y; Kawashima K; Ohno R; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1077-86. PubMed ID: 6582751
[No Abstract] [Full Text] [Related]
32. [Dissociation between the effect on myeloblastoma and the hematologic effect of Ara-C therapy: report of an autopsied myeloblastic leukemia case with around five-year course].
Koyama T; Tohda S; Kamiyama T; Suzuki T; Nagata K; Nakamura Y; Miura O; Maruyama Y; Kato A; Murakami N
Rinsho Ketsueki; 1988 Dec; 29(12):2302-6. PubMed ID: 3246715
[No Abstract] [Full Text] [Related]
33. [8;21 translocation acute myelocytic leukemia developing in the second trimester of pregnancy with successful delivery].
Nakayama M; Takata M; Kato M; Shikoshi K; Umeda M; Tanaka M; Hirakawa S
Rinsho Ketsueki; 1996 Nov; 37(11):1265-70. PubMed ID: 8960659
[TBL] [Abstract][Full Text] [Related]
34. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
Vogler WR; Velez-Garcia E; Omura G; Raney M
Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
[No Abstract] [Full Text] [Related]
35. [The curative treatment of adult acute nonlymphocytic leukemia].
Uzuka Y; Saito Y
Rinsho Ketsueki; 1989 Aug; 30(8):1163-6. PubMed ID: 2601025
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Zittoun R; Suciu S; Mandelli F; de Witte T; Thaler J; Stryckmans P; Hayat M; Peetermans M; Cadiou M; Solbu G; Petti MC; Willemze R
J Clin Oncol; 1996 Jul; 14(7):2150-9. PubMed ID: 8683249
[TBL] [Abstract][Full Text] [Related]
37. [Progress of chemotherapy in adult acute leukemia].
Ohno R
Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
[TBL] [Abstract][Full Text] [Related]
38. [AML-7 study of the value of intensive remission induction in aged patients with acute myelocytic leukemia].
Jehn U; Löwenberg B
Onkologie; 1985 Apr; 8(2):97-8. PubMed ID: 3889758
[TBL] [Abstract][Full Text] [Related]
39. [Chemotherapy of adult ANLL].
Kyo T; Maehama S
Rinsho Ketsueki; 1989 Aug; 30(8):1157-62. PubMed ID: 2601024
[TBL] [Abstract][Full Text] [Related]
40. [Successful pregnancy after 6 years complete remission in patient with acute myeloblastic leukemia].
Shimazaki C; Oku N; Gotoh H; Inaba T; Murakami S; Oku N; Itoh K; Nakanishi S; Nakagawa M; Fujita N
Rinsho Ketsueki; 1991 Jan; 32(1):71-2. PubMed ID: 2020123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]